Sarcoidosis requiring systemic treatment: why not a steroid-sparing regimen up-front?

Sarcoidosis requiring systemic treatment: why not a steroid-sparing regimen up-front?

Authors

  • N. Sweiss
  • H. Yeager

Downloads

Published

01-06-2010

Issue

Vol. 27 No. 1 (2010)

Section

Editorial

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

1.
Sweiss N, Yeager H. Sarcoidosis requiring systemic treatment: why not a steroid-sparing regimen up-front?. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2010 Jun. 1 [cited 2025 Jun. 22];27(1):3-4. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/2560